Our mission is to deliver the greatest possible impact to people through mRNA medicines.
At Moderna, we believe messenger RNA, or mRNA, is the “software of life.”
Every cell in the body uses mRNA to provide real-time instructions to make the proteins necessary to drive all aspects of biology, including in human health and disease.
Given its essential role, we believe mRNA could be used to create a new category of medicines with significant potential to improve the lives of patients.
We are pioneering a new class of medicines made of messenger RNA, or mRNA. The potential implications of using mRNA as a drug are significant and far-reaching and could meaningfully improve how medicines are discovered, developed and manufactured.
To learn more, visit www.modernatx.com.
This Moderna page is not the appropriate place to report adverse events (side-effects) for any products. If you are or someone you know is experiencing a side effect, please reach out to your healthcare professional. Moderna is continuously monitoring the safety of its products. We encourage you to report any side effects directly to us at 1‐866‐MODERNA (1‐866‐663‐3762).
Biotechnology and mRNA Therapeutics
Pioneering mRNA technology - Moderna France
Entity | Type | Tweets | Articles | |
---|---|---|---|---|
ActionAid UK edtech, Non-profit Organizations | Other 31 Mar 2022 | | ||
The Founder Hour Broadcast Media Production and Distribution | Other 31 Jul 2022 | | ||
Apply Digital uxtech, Software Development | Other 11 Aug 2022 | | ||
Stein IAS martech, Advertising Services | Other 18 Aug 2022 | | ||
Bloomberg Government Information Services | Other 22 Aug 2022 | | ||
Ärzte ohne Grenzen Deutschland/ Médecins Sans Frontières healthtech, Non-profit Organizations | Other 3 Sep 2022 | | ||
Les Jours Newspaper Publishing | Other 8 Sep 2022 | | ||
CVS Health healthtech, Hospitals and Health Care | Other 9 Sep 2022 | | ||
FSPF civictech, Civic and Social Organizations | Other 3 Oct 2022 | | ||
IAVI deeptech, healthtech, Research Services | Other 18 May 2022 8 Oct 2022 | | |